Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | EGFR | P00533 | 2/20 | 0.51 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL702504 | 0.87 | NPSR1 (0.47) | TSHREGFRPOLBNPSR1MAPT | |
| SCHEMBL916250 | 0.86 | TSHR (0.54) | TSHREGFRHSPA5AKR1B1POLB | |
| SCHEMBL915739 | 0.83 | EGFR (0.47) | TSHREGFRPOLBMEN1KMT2A | |
| SCHEMBL11715486 | 0.83 | TSHR (0.60) | TSHR | |
| SCHEMBL11710711 | 0.81 | TSHR (0.53) | TSHREGFRHSPA5AKR1B1IDO1 | |
| SCHEMBL8118478 | 0.81 | TSHR (0.48) | TSHREGFRHSPA5AKR1B1POLB | |
| SCHEMBL14045287 | 0.80 | TSHR (0.49) | TSHRPOLBHTR1A | |
| SCHEMBL916350 | 0.80 | CCNT1 (0.43) | TSHREGFRPOLBNPSR1MAPT | |
| SCHEMBL12212067 | 0.80 | NPSR1 (0.42) | TSHREGFRPOLBNPSR1MAPT | |
| SCHEMBL21259132 | 0.79 | EGFR (0.55) | TSHREGFRPOLBMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250298333-A1 | POLYESTER RESIN COMPOSITION, ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, DEVELOPER, AND IMAGE FORMING METHOD | Konica Minolta, Inc. (JP) | 2025-09-25 | — | — | US | disclosed |
| US-11873315-B2 | Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel Brønsted acid catalysts | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) | 2024-01-16 | — | — | US | disclosed |
| US-11873315-B2 | Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel Brønsted acid catalysts | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) | 2024-01-16 | — | — | US | disclosed |
| US-11873315-B2 | Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel Brønsted acid catalysts | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) | 2024-01-16 | — | — | US | disclosed |
| US-20220144868-A1 | CHIRAL N-HETEROCYCLIC PHOSPHORODIAMIDIC ACIDS (NHPAS) AND DERIVATIVES AS NOVEL BRONSTED ACID CATALYSTS | The Board of Regents of the Nevada System of Higher Education on Behalf of the Univ of Nevada (US) | 2022-05-12 | — | — | US | disclosed |
| US-20220144868-A1 | CHIRAL N-HETEROCYCLIC PHOSPHORODIAMIDIC ACIDS (NHPAS) AND DERIVATIVES AS NOVEL BRONSTED ACID CATALYSTS | The Board of Regents of the Nevada System of Higher Education on Behalf of the Univ of Nevada (US) | 2022-05-12 | — | — | US | disclosed |
| US-11248014-B2 | Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel bronsted acid catalysts | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) | 2022-02-15 | — | — | US | disclosed |
| US-11248014-B2 | Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel bronsted acid catalysts | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) | 2022-02-15 | — | — | US | disclosed |
| US-20210147457-A1 | CHIRAL N-HETEROCYCLIC PHOSPHORODIAMIDIC ACIDS (NHPAS) AND DERIVATIVES AS NOVEL BRONSTED ACID CATALYSTS | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS | 2021-05-20 | — | — | US | disclosed |
| US-20210147457-A1 | CHIRAL N-HETEROCYCLIC PHOSPHORODIAMIDIC ACIDS (NHPAS) AND DERIVATIVES AS NOVEL BRONSTED ACID CATALYSTS | THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS | 2021-05-20 | — | — | US | disclosed |
| US-20070196750-A1 | IMAGE BEARING MEMBER, AND IMAGE FORMING APPARATUS AND PROCESS CARTRIDGE USING THE SAME | RICOH COMPANY, LIMITED. (JP) | 2007-08-23 | — | — | US | disclosed |
| US-20070196749-A1 | IMAGE BEARING MEMBER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | RICOH COMPANY, LIMITED (JP) | 2007-08-23 | — | — | US | disclosed |
| US-20070009818-A1 | Electrophotographic photoreceptor and method of preparing the photoreceptor, and image forming method, image forming apparatus and process cartridge therefor using the photoreceptor | RICOH COMPANY, LTD. (JP) | 2007-01-11 | — | — | US | disclosed |
| EP-1742112-A1 | Electrophotographic photoreceptor and method of preparing the photoreceptor, and image forming method, image forming apparatus and process cartridge therefor using the photoreceptor | Ricoh Company, Ltd. (JP) | 2007-01-10 | — | — | EP | disclosed |
| US-20060078809-A1 | Electrophotographic photoreceptor, and image forming method, image forming apparatus and process cartridge using the electrophotographic photoreceptor | RICOH COMPANY, LTD. (JP) | 2006-04-13 | — | — | US | disclosed |
| US-6548042-B2 | Such as tetraethyl-N-(m-trimethylsilylphenylethyl)amino-methylenebisphosphonate for palliative and curative treatment of bone disorders and breast cancer | ARSTAD ERIK (NO) | 2003-04-15 | — | — | US | disclosed |
| US-20020042539-A1 | Bis-phosphonate compounds | ARSTAD ERIK (NO) | 2002-04-11 | — | — | US | disclosed |
| EP-0295729-B1 | INTRAMOLECULAR NUCLEOPHILIC DISPLACEMENT COMPOUND AND USE IN PHOTOGRAPHY | AGFA-GEVAERT N.V. (BE) | 1991-09-04 | — | — | EP | disclosed |
| US-4912028-A | Alkali permeable hydrophilic colloid | AGFA-GEVAERT, N.V. (BE) | 1990-03-27 | — | — | US | disclosed |
| EP-0295729-A1 | Intramolecular nucleophilic displacement compound and use in photography | AGFA-GEVAERT N.V. (BE) | 1988-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147457-A1 | CHIRAL N-HETEROCYCLIC PHOSPHORODIAMIDIC ACIDS (NHPAS) AND DERIVATIVES AS NOVEL BRONSTED ACID CATALYSTS | ELANE, PNKP, NHERF1 | TSHR 3006/4885EGFR 2426/4885HSPA5 3993/4885 |
| US-11248014-B2 | Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel bronsted acid catalysts | ELANE, PNKP, NHERF1 | TSHR 3006/4885EGFR 2426/4885HSPA5 3993/4885 |
| US-20020042539-A1 | Bis-phosphonate compounds | PHOSPHO1, PTMS, PTEN | TSHR 1944/4885EGFR 460/4885HSPA5 4038/4885 |
| US-11873315-B2 | Chiral n-heterocyclic phosphorodiamidic acids (NHPAS) and derivatives as novel Brønsted acid catalysts | ELANE, PNKP, SERPINB1 | TSHR 2516/4885EGFR 2498/4885HSPA5 4261/4885 |
| US-20220144868-A1 | CHIRAL N-HETEROCYCLIC PHOSPHORODIAMIDIC ACIDS (NHPAS) AND DERIVATIVES AS NOVEL BRONSTED ACID CATALYSTS | ELANE, PNKP, NHERF1 | TSHR 3006/4885EGFR 2426/4885HSPA5 3993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.